Table 6 Prognostic factors associated with prolonged time (≥7 days) taken for temperature normalization in PLA patients
Variable (N = 332) | Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|---|
< 7 days N = 174 | ≥ 7 days N = 158 | P value | OR (95% CI) | P value | |
Age (years; median, range) | 57(20–89) | 59(18–84) | 0.385 | ||
Gender (Male/Female) | 108/66 | 79/79 | 0.027 | 1.767(1.017–3.070) | 0.012 |
Etiologies (n, %) | |||||
Biliary source | 64(36.8%) | 43(27.2%) | 0.063 | ||
Portal vein seeding, bowel and/or pelvic pathology | 13(7.5%) | 16(10.1%) | 0.392 | ||
Hepatic artery seeding | 6(3.4%) | 12(7.6%) | 0.162 | ||
Direct extension | 18(10.3%) | 21(13.3%) | 0.405 | ||
Trauma to the liver | 7(4.0%) | 5(3.2%) | 0.676 | ||
Cryptogenic infection | 65(37.4%) | 61(38.6%) | 0.814 | ||
Comorbidities (n, %) | |||||
Smoking | 52(29.9%) | 38(24.1%) | 0.232 | ||
Drinking | 38(21.8%) | 18(11.4%) | 0.011 | 2.849(1.262–6.430) | 0.012 |
Hypertension | 40(23.0%) | 29(18.4%) | 0.299 | ||
Diabetes mellitus | 58(33.3%) | 48(30.4%) | 0.564 | ||
Hepatobiliary malignant diseases | 19(10.9%) | 21(13.3%) | 0.507 | ||
Cholelithiasis | 74(42.5%) | 49(31.0%) | 0.052 | ||
Cirrhosis | 10(5.7%) | 4(2.5%) | 0.145 | ||
Viral hepatitis | 14(8.0%) | 9(5.7%) | 0.400 | ||
Surgery history | |||||
Abdominal surgery history | 87(50.0%) | 68(43.0%) | 0.204 | ||
Hepatobiliary surgery | 74(42.5%) | 55(34.8%) | 0.150 | ||
Other surgery | 13(8.5%) | 13(8.2%) | 0.798 | ||